Healthcare Value Capital LLC lowered its stake in Fluidigm Co. (NASDAQ:FLDM) by 10.9% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 410,500 shares of the medical research company’s stock after selling 50,000 shares during the quarter. Fluidigm comprises about 7.4% of Healthcare Value Capital LLC’s portfolio, making the stock its 4th biggest holding. Healthcare Value Capital LLC’s holdings in Fluidigm were worth $2,418,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds also recently bought and sold shares of the stock. Virtu KCG Holdings LLC acquired a new stake in Fluidigm in the 2nd quarter valued at about $105,000. Sei Investments Co. lifted its holdings in Fluidigm by 221.7% in the 3rd quarter. Sei Investments Co. now owns 21,668 shares of the medical research company’s stock valued at $109,000 after acquiring an additional 14,932 shares during the last quarter. PDT Partners LLC lifted its holdings in Fluidigm by 56.0% in the 2nd quarter. PDT Partners LLC now owns 27,300 shares of the medical research company’s stock valued at $110,000 after acquiring an additional 9,800 shares during the last quarter. Group One Trading L.P. lifted its holdings in Fluidigm by 336.9% in the 3rd quarter. Group One Trading L.P. now owns 23,155 shares of the medical research company’s stock valued at $117,000 after acquiring an additional 17,855 shares during the last quarter. Finally, Dynamic Technology Lab Private Ltd acquired a new stake in Fluidigm in the 3rd quarter valued at about $123,000. 93.17% of the stock is owned by institutional investors and hedge funds.

Separately, ValuEngine raised shares of Fluidigm from a “strong sell” rating to a “sell” rating in a report on Monday, October 23rd.

In related news, insider Levin Capital Strategies, L.P. acquired 100,576 shares of the business’s stock in a transaction on Wednesday, January 10th. The shares were purchased at an average price of $6.34 per share, for a total transaction of $637,651.84. The transaction was disclosed in a legal filing with the SEC, which is available at the SEC website. In the last 90 days, insiders have acquired 277,392 shares of company stock worth $1,628,502. Corporate insiders own 4.70% of the company’s stock.

Fluidigm Co. (NASDAQ FLDM) remained flat at $$6.59 during midday trading on Tuesday. The stock had a trading volume of 94,600 shares, compared to its average volume of 192,271. The company has a current ratio of 3.02, a quick ratio of 2.46 and a debt-to-equity ratio of 5.00. The stock has a market cap of $254.69, a price-to-earnings ratio of -2.96 and a beta of 3.37. Fluidigm Co. has a 52 week low of $2.52 and a 52 week high of $7.05.

Fluidigm (NASDAQ:FLDM) last posted its quarterly earnings data on Thursday, November 2nd. The medical research company reported ($0.31) earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.37) by $0.06. Fluidigm had a negative return on equity of 134.35% and a negative net margin of 68.27%. analysts anticipate that Fluidigm Co. will post -1.4 earnings per share for the current year.

TRADEMARK VIOLATION NOTICE: “Fluidigm Co. (FLDM) Shares Sold by Healthcare Value Capital LLC” was originally reported by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another website, it was copied illegally and reposted in violation of United States and international trademark & copyright law. The original version of this news story can be read at https://www.watchlistnews.com/fluidigm-co-fldm-shares-sold-by-healthcare-value-capital-llc/1820281.html.

Fluidigm Profile

Fluidigm Corporation creates, manufactures and markets technologies and life science tools focused on the exploration and analysis of single cells, as well as the industrial application of genomics, based upon the Company’s core microfluidics and mass cytometry technologies. The Company operates in the development, manufacturing and commercialization of life science tools for the life science and Ag-Bio industries segment.

Want to see what other hedge funds are holding FLDM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Fluidigm Co. (NASDAQ:FLDM).

Institutional Ownership by Quarter for Fluidigm (NASDAQ:FLDM)

Receive News & Ratings for Fluidigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Fluidigm and related companies with MarketBeat.com's FREE daily email newsletter.